Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study
Dermatology · 2023
DOI: 10.1159/000530077 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Dermatology, 2023. Verfasst von Chin-Hsiao Tseng. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Hidradenitis Suppurativa, Acne Vulgaris. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Metformin’s effects on non-cancer skin diseases are rarely investigated.
Objective
The aim of the study was to investigate immune-mediated (urticaria, allergic contact dermatitis, and psoriasis) and androgen-mediated (acanthosis nigricans, hidradenitis suppurativa, and acne) skin diseases associated with metformin use.
Methods
Metformin initiators (n = 234,585) and non-metformin initiators (n = 125,921) within the initial 12 months of antidiabetic drug prescription during 1999–2009 were followed up until December 31, 2011. Cox regression weighted for propensity score was used to estimate hazard ratios for metformin initiators versus non-metformin initiators in intention-to-treat (ITT) and per-protocol (PP) analyses.
Results
For immune-mediated skin diseases, hazard ratios were 0.930 (95% confidence interval: 0.920–0.940) and 0.930 (0.918–0.943) in ITT and PP analyses, respectively, and the hazard ratios for each specific outcome were all significantly below unity. For androgen-mediated skin diseases, the ITT and PP hazard ratios were 1.110 (1.060–1.162) and 0.990 (0.935–1.048), respectively, and all hazard ratios were not significant for each specific outcome except for acne in the ITT analysis (hazard ratio: 1.116, 95% confidence interval: 1.064–1.170).
Conclusion
Metformin use is associated with a significantly lower risk of immune-mediated skin diseases but lacks a preventive effect on androgen-mediated skin diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- National Institute of Environmental Health Sciences of the National Health Research Institutes, Zhunan, Taiwan.
Zitieren
APA
Tseng, C. H. (2023). Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study. Dermatology. https://doi.org/10.1159/000530077
Vancouver
Tseng CH. Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study. Dermatology. 2023. doi:10.1159/000530077
BibTeX
@article{Tseng2023,
author = {Tseng, Chin-Hsiao},
title = {Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study},
journal = {Dermatology},
year = {2023},
doi = {10.1159/000530077}
}
EUVIMED